Study of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone for the Treatment of TNBC (TRYbeCA-2)
Clinical trial NCT03674242 · TERMINATED
Trial details
- NCT number
- NCT03674242
- Sponsor
- ERYtech Pharma
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-13
- Primary completion
- 2022-03-31
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.